Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent HPV Vaccine in HIV-1-Infected Females
NCT00604175Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 2008
- Primary completion
- Jan 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 2 trial of quadrivalent human papillomavirus vaccine in human papillomavirus infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Feb 2008; status: completed.
02
Drugs
quadrivalent human papillomavirus vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT00604175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604175.